 | • レポートコード：QYR9ST05379 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、抗線維化薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口、注射可能、局所に、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、抗線維化薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗線維化薬の世界市場概要 ・抗線維化薬の製造コスト構成分析 ・抗線維化薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗線維化薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗線維化薬のセグメント分析（種類別） （経口、注射可能、局所） ・抗線維化薬のセグメント分析（用途別） （病院薬局、小売薬局、オンライン薬局） ・抗線維化薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Pfizer、Novartis、Sanofi、Merck、Roche、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb） ・抗線維化薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β. This growth factor may derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of extracellular matrix proteins By dermal fibroblasts. Anti-Fibrotic Drug as treatment of cutaneous fibrosis that stops the action of TGF-β, reducing the amount of fibrosis.
The global Antifibrotic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antifibrotic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antifibrotic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antifibrotic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antifibrotic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Novartis
Sanofi
Merck
Roche
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Oral
Injectable
Topical
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
Executive Summary
1 Industry Overview of Antifibrotic Drugs
1.1 Definition of Antifibrotic Drugs
1.2 Antifibrotic Drugs Segment by Type
1.2.1 Global Antifibrotic Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Injectable
1.2.4 Topical
1.3 Antifibrotic Drugs Segment by Applications
1.3.1 Global Antifibrotic Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Antifibrotic Drugs Overall Market
1.4.1 Global Antifibrotic Drugs Revenue (2014-2025)
1.4.2 Global Antifibrotic Drugs Production (2014-2025)
1.4.3 North America Antifibrotic Drugs Status and Prospect (2014-2025)
1.4.4 Europe Antifibrotic Drugs Status and Prospect (2014-2025)
1.4.5 China Antifibrotic Drugs Status and Prospect (2014-2025)
1.4.6 Japan Antifibrotic Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Antifibrotic Drugs Status and Prospect (2014-2025)
1.4.8 India Antifibrotic Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antifibrotic Drugs
2.3 Manufacturing Process Analysis of Antifibrotic Drugs
2.4 Industry Chain Structure of Antifibrotic Drugs
3 Development and Manufacturing Plants Analysis of Antifibrotic Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Antifibrotic Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Antifibrotic Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Antifibrotic Drugs Production and Capacity Analysis
4.2 Antifibrotic Drugs Revenue Analysis
4.3 Antifibrotic Drugs Price Analysis
4.4 Market Concentration Degree
5 Antifibrotic Drugs Regional Market Analysis
5.1 Antifibrotic Drugs Production by Regions
5.1.1 Global Antifibrotic Drugs Production by Regions
5.1.2 Global Antifibrotic Drugs Revenue by Regions
5.2 Antifibrotic Drugs Consumption by Regions
5.3 North America Antifibrotic Drugs Market Analysis
5.3.1 North America Antifibrotic Drugs Production
5.3.2 North America Antifibrotic Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Antifibrotic Drugs Import and Export
5.4 Europe Antifibrotic Drugs Market Analysis
5.4.1 Europe Antifibrotic Drugs Production
5.4.2 Europe Antifibrotic Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Antifibrotic Drugs Import and Export
5.5 China Antifibrotic Drugs Market Analysis
5.5.1 China Antifibrotic Drugs Production
5.5.2 China Antifibrotic Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Antifibrotic Drugs Import and Export
5.6 Japan Antifibrotic Drugs Market Analysis
5.6.1 Japan Antifibrotic Drugs Production
5.6.2 Japan Antifibrotic Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Antifibrotic Drugs Import and Export
5.7 Southeast Asia Antifibrotic Drugs Market Analysis
5.7.1 Southeast Asia Antifibrotic Drugs Production
5.7.2 Southeast Asia Antifibrotic Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Antifibrotic Drugs Import and Export
5.8 India Antifibrotic Drugs Market Analysis
5.8.1 India Antifibrotic Drugs Production
5.8.2 India Antifibrotic Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Antifibrotic Drugs Import and Export
6 Antifibrotic Drugs Segment Market Analysis (by Type)
6.1 Global Antifibrotic Drugs Production by Type
6.2 Global Antifibrotic Drugs Revenue by Type
6.3 Antifibrotic Drugs Price by Type
7 Antifibrotic Drugs Segment Market Analysis (by Application)
7.1 Global Antifibrotic Drugs Consumption by Application
7.2 Global Antifibrotic Drugs Consumption Market Share by Application (2014-2019)
8 Antifibrotic Drugs Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Antifibrotic Drugs Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis Antifibrotic Drugs Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sanofi
8.3.1 Sanofi Antifibrotic Drugs Production Sites and Area Served
8.3.2 Sanofi Product Introduction, Application and Specification
8.3.3 Sanofi Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Merck
8.4.1 Merck Antifibrotic Drugs Production Sites and Area Served
8.4.2 Merck Product Introduction, Application and Specification
8.4.3 Merck Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Roche
8.5.1 Roche Antifibrotic Drugs Production Sites and Area Served
8.5.2 Roche Product Introduction, Application and Specification
8.5.3 Roche Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bayer
8.6.1 Bayer Antifibrotic Drugs Production Sites and Area Served
8.6.2 Bayer Product Introduction, Application and Specification
8.6.3 Bayer Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Boehringer Ingelheim
8.7.1 Boehringer Ingelheim Antifibrotic Drugs Production Sites and Area Served
8.7.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.7.3 Boehringer Ingelheim Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bristol-Myers Squibb
8.8.1 Bristol-Myers Squibb Antifibrotic Drugs Production Sites and Area Served
8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.8.3 Bristol-Myers Squibb Antifibrotic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Antifibrotic Drugs Market
9.1 Global Antifibrotic Drugs Market Trend Analysis
9.1.1 Global Antifibrotic Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Antifibrotic Drugs Regional Market Trend
9.2.1 North America Antifibrotic Drugs Forecast 2019-2025
9.2.2 Europe Antifibrotic Drugs Forecast 2019-2025
9.2.3 China Antifibrotic Drugs Forecast 2019-2025
9.2.4 Japan Antifibrotic Drugs Forecast 2019-2025
9.2.5 Southeast Asia Antifibrotic Drugs Forecast 2019-2025
9.2.6 India Antifibrotic Drugs Forecast 2019-2025
9.3 Antifibrotic Drugs Market Trend (Product Type)
9.4 Antifibrotic Drugs Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Antifibrotic Drugs Distributors List
10.3 Antifibrotic Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Antifibrotic Drugs
Table Global Antifibrotic Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Antifibrotic Drugs Production Market Share by Types in 2018
Figure Oral Product Picture
Figure Injectable Product Picture
Figure Topical Product Picture
Table Global Antifibrotic Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Antifibrotic Drugs Consumption Market Share by Applications in 2018
Figure Hospitals Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Global Antifibrotic Drugs Revenue (Million USD) (2014-2025)
Figure Global Antifibrotic Drugs Production (K Units) (2014-2025)
Figure North America Antifibrotic Drugs Market Size (Million USD) (2014-2025)
Figure Europe Antifibrotic Drugs Market Size (Million USD) (2014-2025)
Figure China Antifibrotic Drugs Market Size (Million USD) (2014-2025)
Figure Japan Antifibrotic Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Antifibrotic Drugs Market Size (Million USD) (2014-2025)
Figure India Antifibrotic Drugs Market Size (Million USD) (2014-2025)
Table Antifibrotic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antifibrotic Drugs in 2018
Figure Manufacturing Process Analysis of Antifibrotic Drugs
Figure Industry Chain Structure of Antifibrotic Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Antifibrotic Drugs Manufacturing Plants Distribution
Table Antifibrotic Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Antifibrotic Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Antifibrotic Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Antifibrotic Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Antifibrotic Drugs Production Share by Manufacturers in 2018
Table Antifibrotic Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Antifibrotic Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Antifibrotic Drugs Revenue Share by Manufacturers in 2018
Table Antifibrotic Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Antifibrotic Drugs Production by Regions 2014-2019 (K Units)
Table Global Antifibrotic Drugs Production Market Share by Regions 2014-2019
Figure Global Antifibrotic Drugs Production Market Share by Regions in 2018
Table Global Antifibrotic Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Antifibrotic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Antifibrotic Drugs Revenue Market Share by Regions in 2018
Table Global Antifibrotic Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Antifibrotic Drugs Consumption Market Share by Regions 2014-2019
Figure North America Antifibrotic Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Antifibrotic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Antifibrotic Drugs Production, Consumption Import and Export (K Units)
Figure Europe Antifibrotic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Antifibrotic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Antifibrotic Drugs Production, Consumption Import and Export (K Units)
Figure China Antifibrotic Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Antifibrotic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Antifibrotic Drugs Production, Consumption Import and Export (K Units)
Figure Japan Antifibrotic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Antifibrotic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Antifibrotic Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Antifibrotic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Antifibrotic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Antifibrotic Drugs Production, Consumption Import and Export (K Units)
Figure India Antifibrotic Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Antifibrotic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Antifibrotic Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Antifibrotic Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Antifibrotic Drugs Market Share by Application (2014-2019)
Table Pfizer Antifibrotic Drugs Production Sites and Area Served
Table Pfizer Antifibrotic Drugs Product Introduction, Application and Specification
Table Pfizer Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Pfizer Antifibrotic Drugs Production Market Share (2014-2019)
Figure Pfizer Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Pfizer Antifibrotic Drugs Main Business and Markets Served
Table Novartis Antifibrotic Drugs Production Sites and Area Served
Table Novartis Antifibrotic Drugs Product Introduction, Application and Specification
Table Novartis Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Novartis Antifibrotic Drugs Production Market Share (2014-2019)
Figure Novartis Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Novartis Antifibrotic Drugs Main Business and Markets Served
Table Sanofi Antifibrotic Drugs Production Sites and Area Served
Table Sanofi Antifibrotic Drugs Product Introduction, Application and Specification
Table Sanofi Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Sanofi Antifibrotic Drugs Production Market Share (2014-2019)
Figure Sanofi Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Sanofi Antifibrotic Drugs Main Business and Markets Served
Table Merck Antifibrotic Drugs Production Sites and Area Served
Table Merck Antifibrotic Drugs Product Introduction, Application and Specification
Table Merck Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Merck Antifibrotic Drugs Production Market Share (2014-2019)
Figure Merck Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Merck Antifibrotic Drugs Main Business and Markets Served
Table Roche Antifibrotic Drugs Production Sites and Area Served
Table Roche Antifibrotic Drugs Product Introduction, Application and Specification
Table Roche Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Roche Antifibrotic Drugs Production Market Share (2014-2019)
Figure Roche Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Roche Antifibrotic Drugs Main Business and Markets Served
Table Bayer Antifibrotic Drugs Production Sites and Area Served
Table Bayer Antifibrotic Drugs Product Introduction, Application and Specification
Table Bayer Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Bayer Antifibrotic Drugs Production Market Share (2014-2019)
Figure Bayer Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Bayer Antifibrotic Drugs Main Business and Markets Served
Table Boehringer Ingelheim Antifibrotic Drugs Production Sites and Area Served
Table Boehringer Ingelheim Antifibrotic Drugs Product Introduction, Application and Specification
Table Boehringer Ingelheim Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Antifibrotic Drugs Production Market Share (2014-2019)
Figure Boehringer Ingelheim Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Antifibrotic Drugs Main Business and Markets Served
Table Bristol-Myers Squibb Antifibrotic Drugs Production Sites and Area Served
Table Bristol-Myers Squibb Antifibrotic Drugs Product Introduction, Application and Specification
Table Bristol-Myers Squibb Antifibrotic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Antifibrotic Drugs Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Antifibrotic Drugs Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Antifibrotic Drugs Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Antifibrotic Drugs Main Business and Markets Served
Figure Global Antifibrotic Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Antifibrotic Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Antifibrotic Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Antifibrotic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Antifibrotic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Antifibrotic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Antifibrotic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Antifibrotic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Antifibrotic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Antifibrotic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Antifibrotic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Antifibrotic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Antifibrotic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Antifibrotic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Antifibrotic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Antifibrotic Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Antifibrotic Drugs by Application (2019-2025)
Table Antifibrotic Drugs Distributors List
Table Antifibrotic Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の抗線維化薬市場：専門的調査 Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β. This growth factor may derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of extrace…- OTC外用薬の世界市場：市場規模・現状・予測 Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 世界のオンコロジージェネリック注射薬市場：専門的調査 Generic drugs are essential in oncology because some anticancer drugs are only available as generics. The global Oncology Generic Injectable Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focu…
- 世界の粘液膜類天疱瘡薬市場：専門的調査 Mucous membrane pemphigoid is an autoimmune blistering disorder that is characterized by subepithelial bullae. The global Mucous Membrane Pemphigoid Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This rep…
- 世界のポルフィリン症薬市場：専門的調査 Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. The global Porphyrias Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This …